Diversity in Life Science Programs

Organizational Structures

Existing organizational structures which support the organization-wide initiative to enhance participation by scientists who are U.S. citizens and members of underrepresented groups (African American, Hispanic American or Latin American, Native American or Alaska Native, and Native Hawaiian or Pacific Islander) and women at Keystone Symposia and in the broader life sciences community are as follows:

Board of Directors: A 15-member body comprised of world-renowned scientists.

Scientific Advisory Board: A 70-member body comprised of academic, government and industry scientists from across the United States and other nations.

Diversity Advisory Committee (DAC): A body of established, prominent scientists from academic institutions such as Howard University, Syracuse University, Massachusetts Institute of Technology (MIT), University of New Mexico, and Northwestern University. Industry representatives are also DAC members (Biogen) as well as representatives from science-based non-profits such as the Coalition for Enhancing Diversity in Science (CEDS), Broad Institute, Siemens Foundation, and the Burroughs Wellcome Fund. Federal agencies, such as the National Science Foundation (NSF); the National Oceanic and Atmospheric Administration (NOAA), are also represented. DAC members provide the Director of the Diversity in Life Science Programs (DLSP) portfolio with knowledge, expertise and insight as Keystone Symposia continues to develop strategies and initiatives which foster and result in greater diversity both within the attendee and speaker populations at our meetings.

Diversity Advisory Committee 2018-2020
Dr. Howard Adams, H. G. Adams & Associates
Dr. Anastacia Berzat Awad, Associate Director, Diversity & Inclusion, Novartis Institutes of
   BioMedical Research
Dr. Bruce Birren, Founding Advisor to Broad's Diversity Initiative in Scientific Research
Dr. Jamaine Davis, Assistant Professor, Meharry Medical College (Keystone Symposia Fellow,
   Class of 2015)
Ms. Eboney Hearn, Assistant Dean for Graduate Education, Diversity Initiatives, Massachusetts
   Institute of Technology (MIT)
Dr. A. James Hicks, Program Director, Louis Stokes Alliance for Minority Participation
   (LSAMP), National Science Foundation (NSF)
Dr. Harlan Jones, Director, Center for Diversity and International Programs (CDIP)
   Assistant Professor, Molecular and Medical Genetics,
   University of North Texas Health Science Center
Ms. Marlene Kaplan, Deputy Director of Education and Director of The Educational Partnership Program (EPP),
   National Oceanic and Atmospheric Administration (NOAA)
Dr. Rick Kittles, Professor and Founding Director, Division of Health Equities, Department of Population Sciences
   City of Hope Comprehensive Cancer Center
Dr. George Langford, Professor, Biology and Dean Emeritus of the College of Arts and
   Sciences, Syracuse University
Dr. Michael Lipscomb, Assistant Professor, Howard University
Dr. Kelly Mack, Vice President and Executive Director, Project Kaleidoscope, Office of
   Undergraduate Science Education (PKAL/STEM), American Association of Colleges &
   Universities (AAC&U)
Dr. Dennis Montoya, Associate Project Scientist, University of California, Los Angeles (Keystone
   Symposia Fellow, Class of 2016)
Dr. Thandi Onami, Program Officer, Global Health - HIV Vaccines, Bill and Melinda Gates Foundation
Ms. Angela Sharpe, American Psychological Association
Mr. Rolly Simpson, Senior Program Officer, Biomedical Sciences; Reproductive Sciences,
   Burroughs Wellcome Fund
Dr. Roland Thorpe, Jr., Associate Professor, Department of Health, Behavior, and Society,
   Johns Hopkins University
Dr. David Vigerust, Chief Scientific Officer, MyGenetx Clinical Labs
Dr. Michael Zigmond, Professor of Neurology, Psychiatry, and Neurobiology, University of Pittsburgh

Dr. Thale Jarvis, Keystone Symposia's Chief Scientific Officer, is involved with all of the organization's diversity initiatives. Her training is in Chemistry and Biophysics and her distinguished career includes over 25 years in drug discovery and development. Her work has particularly focused on infectious diseases but has spanned a range of other therapeutic areas including cancer, cardiovascular and inflammatory diseases. She has contributed to multiple IND and NDA filings with the US FDA, has authored over 40 publications and has been an inventor on 13 issued patents.